AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23789885
Drug: High-MW β-glucan
RxNorm normalized name: marine non-gelling gelatin, high MW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-MW β-glucan (4 g)
Trial: 23789885
Drug: Low-MW β-glucan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-MW β-glucan (4 g)
Trial: 23789885
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml β-glucan beverage
Trial: 23789885
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml β-glucan beverage
Trial: 22022222
Drug: Learning style-tailored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Learning style-tailored education materials (information prescriptions)
Trial: 19226535
Drug: Rapid tryptophan
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rapid tryptophan depletion (RTD) administered within an amino acid drink lacking tryptophan
Trial: 16445305
Drug: Bemiparin plus
RxNorm normalized name: bemiparin
DrugBank: Bemiparin (DB09258)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bemiparin plus oral anticoagulants (OAC) for 3 months
Trial: 16445305
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) plus OAC
Trial: 14727208
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B deoxycholate (1 mg/kg on alternate days for 30 days)
Trial: 14727208
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (2 mg/kg per day for 5 days)
Trial: 14727208
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B lipid complex (2 mg/kg per day for 5 days)
Trial: 22776409
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D deficiency (defined as serum 25(OH)vitamin D <20 ng/mL)
Trial: 20356486
Drug: 7-day levofloxacin-based
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 7-day levofloxacin-based triple therapy (amoxicillin, levofloxacin, lansoprazole)
Trial: 20356486
Drug: 7-day standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day standard triple therapy (clarithromycin, amoxicillin, lansoprazole)
Trial: 12107601
Drug: Suplatast tosilate
RxNorm normalized name: Edoxaban Tosylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suplatast tosilate (100 mg three times daily)
Trial: 10095821
Drug: 800 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 micrograms day‐1 of inhaled budesonide
Trial: 10095821
Drug: 1600 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 micrograms day‐1 of inhaled budesonide
Trial: 10095821
Drug: 800 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 micrograms day‐1 of inhaled budesonide plus placebo
Trial: 10095821
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg day‐1 of prednisone
Trial: 7477193
Drug: High-dose nadroparin
RxNorm normalized name: nadroparin
DrugBank: Nadroparin (DB08813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nadroparin (4100 anti-factor Xa IU twice daily)
Trial: 7477193
Drug: Low-dose nadroparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nadroparin (4100 IU once daily)
Trial: 24484373
Drug: Online cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online cognitive-behavioral therapy (CBT) for pain management + standard care (n = 17)
Trial: 24484373
Drug: Online cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online cognitive-behavioral therapy (CBT) for pain management
Trial: 22100010
Drug: Managing Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Managing Oral Hygiene Using Threat Reduction
Trial: 19018805
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus tri‐iodothyronine (T(3))
Trial: 15565603
Drug: 180 mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 mug pegylated interferon alpha‐2a once weekly plus daily ribavirin
Trial: 11686357
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (100 IU/kg bolus followed by infusion for 3 days, titrated to maintain aPTT between 70 and 90 s)
Trial: 7874374
Drug: Pancuronium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (0.1 mg/kg i.v.)
Trial: 7874374
Drug: Pipecuronium (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipecuronium (0.07 mg/kg i.v.)
Trial: 2896868
Drug: Branched-chain amino
RxNorm normalized name: Branched-chain amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branched-chain amino acids (12 g L-leucine, 8 g L-isoleucine, 6.4 g L-valine)
Trial: 24391768
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV vaccine (Gardasil™)
Trial: 18436090
Drug: Standard dialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dialysis regimen (4 hours 3 times weekly)
Trial: 10930964
Drug: Elixir (30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elixir (30-40 mg kg-1)
Trial: 10930964
Drug: Glycogelatin capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycogelatin capsule suppository (30-40 mg kg-1)
Trial: 10930964
Drug: Triglyceride base
RxNorm normalized name: CAPRYLIC TRIGLYCERIDE
DrugBank: Tricaprylin (DB12176)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triglyceride base suppository (30-40 mg kg-1)
Trial: 10930964
Drug: Elixir
RxNorm normalized name: Elixir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elixir
Trial: 31648910
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of quadrivalent HPV vaccine at 6 months interval
Trial: 24522201
Drug: Quinine MR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine MR with 10 mg rifampicin
Trial: 24522201
Drug: Quinine MR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine MR with 20 mg rifampicin
Trial: 24522201
Drug: Quinine MR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine MR with 100 mg rifampicin
Trial: 15139942
Drug: Intravenous patient-controlled-analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled-analgesia
Trial: 11813383
Drug: Rinsing with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rinsing with a higher volume of water (10 x 3 mL)
Trial: 11813383
Drug: Rinsing with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rinsing with a lower volume of water (5 mL)
Trial: 7995001
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ketoconazole
Trial: 2691002
Drug: 2.5% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% glucose + glucose polymer (group G + GP)
Trial: 2691002
Drug: 2.5% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% glucose (group G)
Trial: 812895
Drug: Cromolyn sodium
RxNorm normalized name: Cromolyn Sodium
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium powder, 20 mg three times daily
Trial: 28954261
Drug: Atraumatic Restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic Restorative Treatment (ART) with High-Viscosity Glass-Ionomer Cement (HVGIC) sealants
Trial: 22615291
Drug: Tablet A
RxNorm normalized name: tablet administration aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet A (100 mg)
Trial: 22615291
Drug: Tablet B
RxNorm normalized name: Biaxin 4 Tablet Blister Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet B (100 mg)
Trial: 6683539
Drug: Capsule (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule (100 mg)
Trial: 22615291
Drug: Oral suspension
RxNorm normalized name: Oral Suspension
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral suspension (control)
Trial: 22615291
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations of posaconazole (100 mg)
Trial: 17433383
Drug: Vision Restoration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vision Restoration Therapy (VRT)
Trial: 12555626
Drug: Transdermal 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 10 mg nitroglycerine patch (12 hours)
Trial: 12555626
Drug: Long-acting oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting oral 40 mg isosorbide-5-mononitrate (once a day)
Trial: 2195921
Drug: Combination methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combination methylprednisolone and placebo troleandomycin
Trial: 2195921
Drug: Troleandomycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troleandomycin (250 mg once daily or every other day)
Trial: 2195921
Drug: Low-dose TAO
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose TAO combined with MPn
Trial: 391624
Drug: Cinnarizine treatment
RxNorm normalized name: cinnarizine
DrugBank: Cinnarizine (DB00568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine treatment
Trial: 29951850
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (n = 20)
Trial: 19458319
Drug: Dose-matched CIMT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-matched CIMT
Trial: 19458319
Drug: Traditional UE
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional UE therapy (Control)
Trial: 17877827
Drug: Room temperature
RxNorm normalized name: ROOM DEODORIZER POWDER MENTOR #3202
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Room temperature irrigation and intravenous fluids
Trial: 17877827
Drug: Warmed irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warmed irrigation fluid at 38 degrees C and room temperature intravenous fluid
Trial: 17877827
Drug: Warmed irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warmed irrigation fluid and warmed intravenous fluids at 38 degrees C
Trial: 14687858
Drug: sertraline (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sertraline (50‐200 mg/day)
Trial: 14687858
Drug: imipramine (75‐225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: imipramine (75‐225 mg/day)
Trial: 12109659
Drug: Very-high-flow injection-rate
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-high-flow injection-rate method (group A)
Trial: 12109659
Drug: Conventional injection-rate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection-rate method (group B)
Trial: 8948688
Drug: Nifedipine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (average daily dose, 21.5 mg/day) for 4 weeks
Trial: 1632260
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide 200 micrograms b.i.d.
Trial: 79031
Drug: Oral linoleic-acid
RxNorm normalized name: Linoleic acid
DrugBank: Linoleic acid (DB14104)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral linoleic-acid supplementation for 10 months
Trial: 30934797
Drug: 4.5 g
RxNorm normalized name: Zosyn 4.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 g PolyGlycopleX softgel capsules (PGXS)
Trial: 30934797
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g rice flour (RF)
Trial: 26070406
Drug: Paritaprevir plus
RxNorm normalized name: Paritaprevir
DrugBank: Paritaprevir (DB09297)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Paritaprevir plus ritonavir (200/100 mg), ombitasvir (25 mg), and dasabuvir (400 mg)
Trial: 21806904
Drug: No parental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No parental presence during dental treatment
Trial: 16505424
Drug: Shorter time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter time between the first day of chemotherapy and the last day of chest radiation (SER)
Trial: 17145253
Drug: Bupropion (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (300 mg, sustained-release)
Trial: 8905472
Drug: Clonidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (300 micrograms po at 0 min) before and after testosterone replacement (250 mg i.m. every 21 days)
Trial: 6344041
Drug: Aspirin 1300
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 1300 mg
Trial: 18416823
Drug: RAISINS +
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RAISINS + WALK (combination of both interventions)
Trial: 9487836
Drug: 20% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% sodium bicarbonate dentifrice, 1.5% hydrogen peroxide solution, mouth moisturizer
Trial: 9487836
Drug: Crest dentifrice,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crest dentifrice, Toothette Plus with hydrogen peroxide solution, mouth moisturizer
Trial: 9487836
Drug: Crest dentifrice,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crest dentifrice, Toothette Plus with control solution, no mouth moisturizer
Trial: 9487836
Drug: Crest dentifrice,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crest dentifrice, Toothette without baking soda, control solution, no mouth moisturizer
Trial: 12748132
Drug: Single subacromial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subacromial injection of methylprednisolone with bupivicaine (group S, n=54)
Trial: 11076414
Drug: Pumpan (homeopathic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pumpan (homeopathic compound)
Trial: 2071888
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 10 mg doses of vinpocetine
Trial: 2071888
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 20 mg doses of vinpocetine
Trial: 6827767
Drug: Night urinary
RxNorm normalized name: URINARY NIGHT DRAINAGE BOTTLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Night urinary sodium excretion estimated by quantitative chloride titrator strips
Trial: 31427345
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan injection
Trial: 27821083
Drug: Selective Internal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Internal Radiation Therapy (SIRT) using yttrium‐90 resin microspheres (SIR‐Spheres®)
Trial: 27821083
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral Sorafenib (Nexavar®) at a dose of 400 mg twice daily
Trial: 27821083
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral Sorafenib (Nexavar®)
Trial: 18591574
Drug: Aripiprazole (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (mean dose approximately 9 mg/day at endpoint; range = 0.7‐15.0 mg)
Trial: 8771941
Drug: Mebendazole 500
RxNorm normalized name: mebendazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole 500 mg (original manufacturer)
Trial: 8771941
Drug: Mebendazole 500
RxNorm normalized name: mebendazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole 500 mg (locally produced)
Trial: 24924603
Drug: Loxoprofen sodium
RxNorm normalized name: loxoprofen sodium dihydrate
DrugBank: Loxoprofen (DB09212)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Loxoprofen sodium hydrogel patch (LX‐P)
Trial: 24924603
Drug: Loxoprofen sodium
RxNorm normalized name: loxoprofen sodium dihydrate
DrugBank: Loxoprofen (DB09212)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Loxoprofen sodium tablet (LX‐T)
Trial: 20628238
Drug: Infliximab treatment
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab treatment for 1 year
Trial: 16151760
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg IV infused eletriptan
Trial: 7654506
Drug: Thymopentin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin (50 mg s.c. every other day for 4 weeks post-splenectomy)
Trial: 7654506
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no thymopentin treatment)
Trial: 2199642
Drug: Dexamethasone (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1.0 mg/kg/day for 3 days, then progressively decreased for 12 days)
Trial: 342624
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza virus vaccines containing 200 or 400 chicken cell‐agglutinating units of both A/New Jersey/76 and A/Victoria/75 antigens
Trial: 342624
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of vaccines
Trial: 342624
Drug: Later revaccinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Later revaccinations due to low titers of A/Victoria antibody
Trial: 6752800
Drug: Photocoagulation therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photocoagulation therapies
Trial: 29096225
Drug: Mat-based Pilates
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mat-based Pilates training (60-min sessions, twice a week for 16 weeks)
Trial: 18065407
Drug: high CHOEP
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high CHOEP (cyclophosphamide 1400 mg/m2, doxorubicin 65 mg/m2, vincristine 2 mg, etoposide 175 mg/m2 x3, prednisone 100 mg x5)
Trial: 6661892
Drug: Flurbiprofen 250
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 250 mg/day
Trial: 6661892
Drug: Ketoprofen 150
RxNorm normalized name: ketoprofen 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 150 mg/day
Trial: 29749805
Drug: Sodium lactate
RxNorm normalized name: Sodium Lactate
DrugBank: Lactic acid (DB04398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium lactate infusion (NAH w|lac)
Trial: 29749805
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (NAH w|placebo)
Trial: 29749805
Drug: Sodium lactate
RxNorm normalized name: Sodium Lactate
DrugBank: Lactic acid (DB04398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium lactate infusion (IAH w|lac)
Trial: 27569177
Drug: Dance therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dance therapy (8-week, 3-times-per-week programme)
Trial: 27569177
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (usual activities and medication)
Trial: 22704138
Drug: Vigabatrin 3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigabatrin 3000 mg/day
Trial: 12030732
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg t.i.d. for 12 weeks
Trial: 10492107
Drug: Oral 17beta‐oestradiol/oestriol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17beta‐oestradiol/oestriol (Trisequens) with norethisterone acetate
Trial: 10492107
Drug: Transdermal 17beta‐oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta‐oestradiol (Estrapak) with norethisterone acetate
Trial: 8684407
Drug: Terazosin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (10 mg daily)
Trial: 8684407
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of terazosin and finasteride
Trial: 2018208
Drug: 2.0 mg/kg/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg/kg/20 min
Trial: 2018208
Drug: 2.5 mg/kg/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg/20 min
Trial: 2018208
Drug: 2.0 mg/kg/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg/kg/10 min
Trial: 6786069
Drug: verapamil (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil (400 +/- 80 mg/day)
Trial: 6786069
Drug: nifedipine (82
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine (82 +/- 31 mg/day)
Trial: 27777129
Drug: 100mg aspirin
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100mg aspirin
Trial: 27777129
Drug: 300mg aspirin
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300mg aspirin
Trial: 27777129
Drug: 100mg aspirin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100mg aspirin, 300mg aspirin, matched placebo
Trial: 22277663
Drug: Palonosetron (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron (0.075 mg bolus)